On April 3, 2025, Dogwood Therapeutics, Inc. announced it believes it has regained compliance with Nasdaq's $2.5 million stockholders equity requirement after a debt cancellation and stock offering. The company had until December 30, 2024, to submit a plan for compliance after being notified on November 15, 2024, of its non-compliance.